<DOC>
	<DOCNO>NCT02199860</DOCNO>
	<brief_summary>The purpose present study obtain information safety , tolerability pharmacokinetics BIBN 4096 BS single inhalation administration rise dos spray-dried powder healthy male female volunteer . According original protocol , primary objective investigate safety tolerability single dose new spray-dried inhalation formulation BIBN 4096 BS ( SD I ) . Following implementation Amendment 2 , objective extend second spray-dried inhalation formulation SD II without concomitant administration lactose</brief_summary>
	<brief_title>Single Rising Dose Study Investigating Safety , Tolerability Pharmacokinetics Spray Dried BIBN 4096 BS After Inhalation Administration Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<criteria>Subjects could include study meet follow criterion : Healthy male female volunteer Written inform consent accordance Good Clinical Practice ( GCP ) local legislation prior admission study Age 21 50 year Body mass index ( BMI ) : 18.5 29.9 kg/m2 Subjects allow participate follow applied : Any find medical examination ( include blood pressure , pulse rate , Respiratory rate , body temperature ECG ) deviate normal clinical relevance Raw &gt; 3 cm H2O • • L1 FEV1 &lt; 80 % predict Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system , psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackout , Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least 1 month less 10 halflives respective drug enrolment study Use drug might influence result trial ( within 1 week prior administration investigational drug trial ) Participation another trial investigational drug ( within 2 month prior drug administration trial ) Smoker ( &gt; 10 cigarettes/day &gt; 3 cigars/day &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 gram/day ) Drug abuse Blood donation ( ≥100 mL within 4 week prior administration investigational drug trial ) Excessive physical activity ( within last week study ) Any laboratory value outside reference range clinical relevance For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraceptive , sterilization , intrauterine device Inability maintain adequate contraception whole study period , Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>